ProfileGDS4132 / 209101_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 50% 37% 36% 53% 73% 52% 53% 43% 37% 32% 46% 52% 48% 59% 49% 49% 62% 68% 35% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101135.8850
GSM201543Muscle PCOS pioglitazone 12187.372537
GSM201544Muscle PCOS pioglitazone 16193.467936
GSM201545Muscle PCOS pioglitazone 201151.70753
GSM201829Muscle PCOS pioglitazone 231234.20773
GSM201830Muscle PCOS pioglitazon 251146.36252
GSM201831Muscle PCOS pioglitazone 27114653
GSM201832Muscle PCOS pioglitazone 31112.19143
GSM201833Muscle PCOS pioglitazone 4188.801237
GSM201834Muscle PCOS pioglitazone 8176.614732
GSM201835Muscle PCOS after pioglitazone 102106.25546
GSM201836Muscle PCOS after pioglitazone 122128.95152
GSM201837Muscle PCOS after pioglitazone 162111.82148
GSM201838Muscle PCOS after pioglitazone 202156.43659
GSM201839Muscle PCOS after pioglitazone 232122.04949
GSM201840Muscle PCOS after pioglitazone 252126.91249
GSM201841Muscle PCOS after pioglitazone 272160.40762
GSM201842Muscle PCOS after pioglitazone 32173.50568
GSM201843Muscle PCOS after pioglitazone 4285.289835
GSM201844Muscle PCOS after pioglitazone 8299.13940